BAJAJHCARE331.50

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,116 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation31.427.927.5
+ Impairment Loss / (Reversal)0.00.0-0.2
+ Finance Costs41.927.922.2
+ Interest Income-0.30.00.0
+ Fair Value (Gains) / Losses51.40.00.0
+ Unrealised FX (Gain) / Loss1.1-3.9-6.5
+ Other Non-cash Items45.0-5.037.3
+ Other Reconciling Items-87.2-4.0-5.1
Changes in Working Capital
+ Inventories20.4-17.8-54.1
+ Trade Receivables — Current12.6-68.30.0
+ Trade Receivables — Non-current0.00.021.3
+ Other Financial Assets — Non-current0.00.0-23.9
+ Other Current Assets-13.911.00.0
+ Other Bank Balances0.0-0.5-0.3
+ Other Financial Liabilities — Non-current0.012.90.0
+ Other Current Liabilities19.40.08.9
Cash from Operating Activities
Profit Before Tax (per I/S)-16.746.028.930.9
+ Total Adjustments (incl. Working Capital)121.8-19.827.1
Cash from Operations (pre-tax)105.126.256.1
+ Income Taxes Paid12.84.6-2.0
Cash from Operating Activities92.321.658.1
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)30.311.543.3
+ Disp of Fixed Assets11.30.12.9
+ Acq of Subsidiaries / Businesses (net)0.00.08.1
+ Interest Received — Investing0.30.50.3
+ Other Inflows / (Outflows) — Investing7.5-3.90.5
Cash from Investing Activities-11.2-14.8-47.8
Cash from Financing Activities
+ Proceeds from Issue of Shares0.0149.752.6
+ Proceeds from Borrowings0.045.01.0
+ Repayment of Borrowings51.7170.30.7
+ Payment of Lease Liabilities0.20.13.1
+ Interest Paid41.927.921.2
+ Dividends Paid2.82.83.2
+ Other Inflows / (Outflows) — Financing0.00.0-1.1
Cash from Financing Activities-96.6-6.424.3
Net Changes in Cash (pre-FX)-15.50.434.6
Net Changes in Cash-15.50.434.6
Closing Cash2.2
Reference Items
EBITDA76.382.4104.8109.1
EBITDA Margin %16.1115.1917.1517.37
Free Cash Flow (CFO − Capex)62.010.114.714.7
Free Cash Flow to Equity-127.34.4
Free Cash Flow per Basic Share18.423.004.384.38
Price to Free Cash Flow75.75
Cash Flow to Net Income-1.100.553.68
Cash Paid for Taxes12.84.6-2.0
Cash Paid for Interest41.927.921.2
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.